dc.creator | Rocha de Lossada, Carlos | es |
dc.creator | Rachwani Anil, Rahul | es |
dc.creator | Borroni, Davide | es |
dc.creator | Sánchez González, José María | es |
dc.creator | Esteves Marques, Raquel | es |
dc.creator | Soler Ferrández, Fernando Luis | es |
dc.creator | Gegúndez Fernández, José Antonio | es |
dc.creator | Romano, Vito | es |
dc.creator | Livny, Eitan | es |
dc.creator | Rodríguez Calvo de Mora, Marina | es |
dc.date.accessioned | 2022-01-24T12:17:41Z | |
dc.date.available | 2022-01-24T12:17:41Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Rocha de Lossada, C., Rachwani Anil, R., Borroni, D., Sánchez González, J.M., Esteves Marques, R., Soler Ferrández, F.L.,...,Rodríguez Calvo de Mora, M. (2021). New Horizons in the Treatment of Corneal Endothelial Dysfunction. Journal of Ophthalmology, 6644114. | |
dc.identifier.issn | 2090-004X (Print) | es |
dc.identifier.issn | 2090-0058 (Online) | es |
dc.identifier.uri | https://hdl.handle.net/11441/129122 | |
dc.description.abstract | The treatment of corneal endothelial dysfunction has experienced a revolutionary change in the past decades with the emergence
of endothelial keratoplasty techniques: descemet stripping automated endothelial keratoplasty (DSAEK) and descemet membrane
endothelial keratoplasty (DMEK). Recently, new treatments such as cultivated endothelial cell therapy, Rho-kinase inhibitors
(ROCK inhibitors), bioengineered grafts, and gene therapy have been described. ,ese techniques represent new lines of
treatment for endothelial dysfunction. ,eir advantages are to help address the shortage of quality endothelial tissue, decrease the
complications associated with tissue rejection, and reduce the burden of postoperative care following transplantation. Although
further randomized clinical trials are required to validate these findings and prove the long-term efficacy of the treatments, the
positive outcomes in preliminary clinical studies are a stepping stone to a promising future. Our aim is to review the latest available
alternatives and advancements to endothelial corneal transplant. | es |
dc.format | application/pdf | es |
dc.format.extent | 11 p. | es |
dc.language.iso | eng | es |
dc.publisher | Hindawi | es |
dc.relation.ispartof | Journal of Ophthalmology, 6644114. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | New Horizons in the Treatment of Corneal Endothelial Dysfunction | es |
dc.type | info:eu-repo/semantics/article | es |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Física de la Materia Condensada | es |
dc.relation.publisherversion | https://doi.org/10.1155/2021/6644114 | es |
dc.identifier.doi | 10.1155/2021/6644114 | es |
dc.journaltitle | Journal of Ophthalmology | es |
dc.publication.initialPage | 6644114 | es |